Dr. Gillett and Nurse Practitioner James O'Hara delve into the reasons why withholding the publication of studies can be detrimental.
00:00 Intro
01:05 Undisclosed Human Study
07:07 Rapamycin and Ketamine Combination
15:50 Lifespan Impact: SIRT2 Transgenic Over-expression in Mice
18:23 Collaborative FDA Letter Addressing Obesity
21:36 Advocating for the Publication of Surprising Findings
28:32 Insights from Dr. Gillett's Surgical Experience
29:34 Conclusion
Studies/References
► https://clinicaltrials.gov/study/NCT03190785#publications
► https://pubmed.ncbi.nlm.nih.gov/32092760/
► https://onlinelibrary.wiley.com/doi/full/10.1111/acel.14027
► https://acsess.onlinelibrary.wiley.com/doi/full/10.2134/ael2015.10.0007
► https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.15370
For High-quality labs:
► https://gilletthealth.com/order-lab-panels/
For information on the Gillett Health clinic, lab panels, and health coaching:
► https://GillettHealth.com
Follow Gillett Health for more content from James and Kyle
► https://instagram.com/gilletthealth
► https://www.tiktok.com/@gilletthealth
► https://twitter.com/gilletthealth
► https://www.facebook.com/gilletthealth
Follow Kyle Gillett, MD
► https://instagram.com/kylegillettmd
Follow James O’Hara, NP
► https://Instagram.com/jamesoharanp
For 10% off Gorilla Mind products including SIGMA: Use code “GH10”
► https://gorillamind.com/
For discounts on high-quality supplements
►https://www.thorne.com/u/GillettHealth
#podcast #study #discussion #science #gilletthealth
